0R19.LSE Becton Dickinson & Co.

Healthcare Commercial Services & Supplies London Exchange
- USD
Market cap
-
P/E
31.5x
P/B
-
ROE
2.4%
Dividend yield
0.01%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.

Is 0R19.LSE undervalued?

Graham number

The Graham number of Becton Dickinson & Co. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Becton Dickinson & Co. fundamental analysis

No fundamental analysis for Becton Dickinson & Co. yet.

Becton Dickinson & Co. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Becton Dickinson & Co.

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, …

Full company profile